Document Detail

Effect of heliox on albuterol delivery by metered-dose inhaler in pediatric in vitro models of mechanical ventilation.
MedLine Citation:
PMID:  16999649     Owner:  NLM     Status:  MEDLINE    
STUDY OBJECTIVE: To determine the effect of varying concentrations of heliox, a mixture of helium and oxygen, on albuterol delivery administered by metered-dose inhaler (MDI) in pediatric mechanically ventilated models. DESIGN: Prospective in vitro laboratory study. SETTING: University-affiliated research laboratory. MODELS: The lungs of a 10-kg infant and 30-kg child receiving humidified pressure-regulated volume-controlled ventilation were simulated. The infant settings were an endotracheal tube (ETT) of 4.0 mm, tidal volume of 150 ml, positive end-expiratory pressure of 2 cm H(2)O, rate of 20 breaths/minute, inspiratory time of 0.7 second; the child settings were an ETT of 6.0 mm, tidal volume of 450 ml, positive end-expiratory pressure of 2 cm H(2)O, rate of 16 breaths/minute, and inspiratory time of 0.8 second. MEASUREMENTS AND MAIN RESULTS: Ten albuterol MDI canisters with chlorofluorocarbon propellants were each actuated once sequentially (total dose 1000 mug) with a commercially available aerosol holding chamber. Albuterol was collected onto a filter proximal to a lung simulator. The filter was rinsed, and concentrations were determined by high-performance liquid chromatography. In the infant model, heliox mixtures of 70:30, 60:40, and 50:50 were compared with nitrogen:oxygen (N(2):O(2)) mixtures in the same ratios. The effect of the 70:30 mixtures was also explored in a child model. Each gas mixture was tested 5 times. At all three ratios, albuterol delivery to the end of the ETT was improved with heliox compared with N(2):O(2) (approximately 7% vs 3-4%, p<0.0001, one-way analysis of variance [ANOVA] with a Bonferroni correction for multiple comparisons). No significant difference was noted in mean percentage albuterol delivery among the varying ratios of heliox studied. By two-way ANOVA, significantly greater albuterol delivery was noted with 70:30 heliox compared with 70:30 N(2):O(2) (7-8% vs 3%, p<0.0001), with no significant difference between the infant and child model (p=0.21). The gas mixture, model, and interaction of the two explained 88% of the variability in mean percentage albuterol delivery. CONCLUSION: Heliox increased albuterol delivery administered by MDI to the end of the ETT in these in vitro pediatric models of mechanical ventilation. Further studies are needed to determine if the improved albuterol delivery with heliox enhances clinical response in infants and children needing mechanical ventilation.
Sandra S Garner; Donald B Wiest; Charles E Stevens; David M Habib
Related Documents :
16238539 - Effects of open vs. closed system endotracheal suctioning on cerebral blood flow veloci...
23878129 - Commentary on 'prophylactic phototherapy for preventing jaundice in preterm or low birt...
9119259 - Pentane measurement in ventilated infants using a commercially available system.
24639799 - Relationship between maternal periodontal disease and low birth weight babies.
25021269 - Pc.43 transcatheter closure of the patent ductus arteriosus in ex-premature infants i...
18972409 - Nasal nitric oxide in infants before and after extubation.
7359279 - Impedance cardiographic assessment of symptomatic patent ductus arteriosus.
18550299 - Does gestational duration within the normal range predict infant neuromotor development?
15787889 - Infant mortality in israel during 1950-2000: rates, causes, demographic characteristics...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacotherapy     Volume:  26     ISSN:  0277-0008     ISO Abbreviation:  Pharmacotherapy     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-26     Completed Date:  2007-02-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111305     Medline TA:  Pharmacotherapy     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1396-402     Citation Subset:  IM    
Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albuterol / administration & dosage,  pharmacokinetics*
Bronchodilator Agents / administration & dosage,  pharmacokinetics*
Helium / administration & dosage,  pharmacokinetics*
Lung / drug effects*
Metered Dose Inhalers*
Oxygen / administration & dosage,  pharmacokinetics*
Prospective Studies
Respiration, Artificial*
Reg. No./Substance:
0/Aerosols; 0/Bronchodilator Agents; 18559-94-9/Albuterol; 58933-55-4/heliox; 7440-59-7/Helium; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabete...
Next Document:  Life after the women's health initiative: evaluation of postmenopausal symptoms and use of alternati...